Latest Hepatoblastoma News

In honor of Hepatoblastoma Awareness Day 2026, we have created a campaign to widen our reach. Your tax deductible donation will have tangible impact for families affected by hepatoblastoma and other pediatric cancers. May 25, 2026 is Hepatoblastoma Awareness Day, a day we come together to raise awareness and support for families affected by hepatoblastoma and other pediatric liver cancers. Hepatoblastoma Resource Network began as a website resource, founded by Christina and

Although Hepatoblastoma is listed as the 'most common' form of pediatric liver cancer, that is a misnomer, because it is not at all common. Hepatoblastoma accounts for roughly 0.5-2% of all childhood cancer diagnoses. The statistics currently stand at fewer than 1 in 1 million children diagnosed with Hepatoblastoma in the United States annually. Rare Disease Day was established in 2008 by EURORDIS (European Organisation for Rare Diseases) in order to raise awareness for indi

The HRN Parent Team at this year's conference (left to right): Kathy Cundiff, Bibi Fell, Christina Stiverson, Chetana Bisarya, Kristen Grace, Sarah Lansing, and Julie Chessell. This year was a big one for Hepatoblastoma Resource Network- one that was marked with change and progress forward for the Network. Our founder and President, Christina Stiverson has lovingly been referring to our newly resurged team as HRN 2.0! Here's a brief review and some highlights from the year,

When a Child Has Cancer, Financial & Family Support Matters When a child is diagnosed with Hepatoblastoma, the impact ripples far beyond medical treatment. The reality of hospital stays, ongoing care, travel, and disruption to daily life can stretch a family’s finances and emotional reserves to the limit. Especially during the holiday season- this time of year can be exceedingly difficult for a family dealing with a cancer diagnosis, for a variety of reasons. That’s why it’s

Jim Geller, MD is a renowned pediatric oncologist with more than 20 years of experience in his field. He has served as Director of the Liver and Renal Tumor Programs at Cincinnati Children's Hospital, has published over 170 peer-reviewed articles, and has chaired and sponsored numerous multidisciplinary committees and research trials for Children's Oncology Group as well as pharmaceutical companies and regulatory entities. Dr. Geller is currently affiliated with Rady Children

Order your copy on Amazon today Content Warning: Child Loss Grief memoirs are often saturated with sorrow, but few manage to transmute...

Above: Hepatoblastoma survivors and siblings participate in a panel presentation during the Patient and Family Advocacy Day at the 5th...

Second opinions are such a hot topic among parents with children fighting for any disease, not just Hepatoblastoma. The feelings toward...